All over the world, but especially in western countries, there has been a rise in asthma mortality. Air pollution, increasing concentrations of house dust mite allergen, poverty, limited access to adequate medical care among urban minorities, inappropriate use of fl2-adrenergic agonists and underutilization of disease-modifying antiinflammatory therapies have been among the most frequently postulated causes for this worrisome trendl4. This has occurred despite continued gains in our understanding of the underlying inflammatory nature of this disease. Indeed, increasing asthma mortality is a paradox, since the mortality of all other non-malignant chronic illnesses has declined with advances in understanding and treatment5. Table 1 makes some international comparisons for the year 1980. During the past 10 years many countries have begun to fight back against the rising tide of asthma deaths.
The barriers that limit an asthmatic's access to urgent health care, therapeutic drugs, and preventive measures all stem from an individual source namely, lack of adequate patient, family and health-professional education. In this paper we focus on the predicament of their response and the progress they have made.
UNITED KINGDOM
Data from the Annual Report of the Chief Medical Officer of the Department of Health and Social Security published in 1986 clearly revealed an increasing trend in asthma hospital admissions and discharges in the UK between 1957 and 1984. Even if we factor out the clear epidemic of deaths in the mid 1960s related to the beta agonist isoproterenol (which has been withdrawn from the market), the rise in death rate remains and continues through the 1980s (with similar trends in other European countries). Though children did not show an increase in mortality, hospital admissions did rise strikingly. In older patients (age groups 15-44 years, 45-64 years, and 65+ years) a significant increase in mortality has occurred7. It is clear that careful data collection in the national health system has allowed public health experts to identify and respond to these trends: accurate surveillance efforts lead to a better understanding and a rapid response to increasing mortality. Under-treatment, poor case management and lack of patient and family awareness have been proposed as contributing factors for the rising death rate8.
The response in the UK has been direct. Among several initiatives the Asthma Training Centre was established in 1986 to train practice-nurses and physicians in the assessment and clinical management. There have been mixed critiques of the programme9, and we do not yet know whether this sort of training provides a means for reducing asthma mortality.
NEW ZEALAND Similar trends in mortality have been noted in New Zealand; with increasing prevalence of asthma as well as rises in morbidity and mortality. While some of this increase was initially thought to be due to a revision of the code of the International Classification of Diseases and a change in the criteria for diagnosing asthma, these factors did not explain all of the increase. Indeed, an increase in the severity of asthma, management failures, and overuse of 32-adrenergic agonists have subsequently been implicated. However, there is still no certainty that any of them are related directly to overall mortality'0. Mortality increases in New Zealand were partially linked by Crane and colleaguesll to the excessive use offenoterol. Their study revealed that the risk of death for fenoterol users was significantly greater than for other Il2-adrenergic agonists. Though this study was initially criticized, follow-up data led to the worldwide withdrawal of fenoteroll2-14
The medical community of New Zealand sought multiple avenues to counter asthma mortality, the highest in the world. Initiatives included establishing an Asthma Task Force, organizing hospital-based asthma clinics, and dedicating materials and time to the education of health practitioners and the general public. As a result of these efforts, asthma mortality began to decline in the mid 1 980s from a high of about 4 per 100000 to less than one per 100000. Evaluation of asthma drug sales during this time revealed a decrease in inhaled ,82-agonists and an increase in inhaled corticosteroids, so greater use of anti-inflammatory compounds may have been partly responsible for the improvementl5. Reviewing these efforts Kolbe et al.16 concluded that the educational campaigns had greatly contributed to the decline in mortality but emphasized that social, economic, and psychological factors deserve attention, because of their influence on the effectiveness of education.
CANADA
In Canada, too, a rise in asthma mortality prompted a focus on education. Though Canada is a country of wealth, literacy and universal health care, educational efforts have been limited because of its dispersed population and ethnic diversity. As yet, Canada does not have an effective national asthma education programme. However, efforts to coordinate the Canadian Network for Asthma Care are currently underway, The Quebec Asthma Education Network was established in 1991, and is being used as a model for the national network organization. Goals include developing a more uniform approach to asthma treatment and education and achieving a 30% reduction, within 5 years, in asthma morbidity, mortality and time lost from work or school. The network has a research programme designed to determine the efficacy of this system and to optimize existing services17.
UNITED STATES
Between 1980 and 1987 the USA saw increases in the prevalence, morbidity and mortality of asthma, most prominent among children and young adults. United States asthma hospital admissions increased by 4.5% per year during the 1 980s for children under the age of 18. According to the Centers for Disease Control the ageadjusted death rate for asthma steadily increased from 1982 through 1991 with a consistently higher rate for females than for males and a rate higher for blacks than for whites18.
Management of patients within poor urban populations, especially minorities, has been especially problematic. Their mortality far exceeds the national average19'20. One reason for the striking differences is inadequate access to appropriate medical care among urban minorities.
The first formal recognition of the need for asthma education in the USA came in the 1970s from the National Heart, Lung and Blood Institute. Their programmes were directed at children (ages 6-13) and their parents, but failed to address asthma management practices, clinical status or health-care utilization. In 1989 the National Asthma Education and Prevention Program (NAEPP) began to provide information to physicians and patients about control of asthma and treatment options21. The goals of this farreaching asthma education effort are to raise awareness of the seriousness of this chronic illness, ensure recognition of the symptoms of asthma, and promote effective control of asthma22. Despite these efforts asthma deaths continue to rise within the USA. Mortality is exceedingly high among poor urban minorities, and at last attention is being paid to the better access-e.g. via community based clinics in poor neighbourhoods23'23.
ISRAEL
Schwartz and associates25 in 1990 examined mortality due to asthma in Israel, reporting one of the lowest rates in the industrialized world. One factor that can often be improved is communication between physician and patient. As a result of an inner-city study by Bailey and associates27 the asthma education programmes at their institution switched its priorities to increasing cognitive skills, encouraging adherence to medication regimens and providing means to develop social supports. The National Asthma Education Program expert panel in 1991 compiled a list of goals of asthma therapy which included maintaining normal (or near normal) pulmonary function, maintaining normal activity, preventing chronic and troublesome symptoms, preventing recurrent exacerbations and avoiding adverse effects from asthma medication. In compiling an extensive list of topics to be included in an asthma education programme to achieve these goals the panel emphasized the need to keep these goals individualized28'29.
The international trend towards increasing asthma mortality requires a serious response from the global medical community. Without appropriate intervention, asthma mortality may continue to rise. We should hope that, through education and treatment, we can reverse this trend around the world.
